Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Scarfò

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.
Blood|April 19, 2013
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLLAnna Vardi, Antonis Dagklis, Lydia Scarfò, et al.
Leukemia|March 21, 2025
Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in miceChiara Rompietti, Francesco Maria Adamo, Daniele Sorcini, et al.
Hemasphere|July 26, 2023
The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK InhibitorsMarta Sampietro, Valeria Cassina, Domenico Salerno, et al.
Haematologica|May 18, 2019
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemiaMichael Steurer, Marco Montillo, Lydia Scarfò, et al.
Blood|May 4, 2017
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosisFrancesca Gorini, Laura Azzimonti, Gloria Delfanti, et al.
Blood|January 31, 2016
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironmentRoberta Valsecchi, Nadia Coltella, Daniela Belloni, et al.
Blood|August 3, 2022
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLLLydia Scarfò, Silvia Heltai, Elisa Albi, et al.
Nature Communications|December 30, 2025
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1Paolo G Cocomazzi, Anastasia Iatrou, Claudia Minici, et al.
Blood|October 28, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Inna Y Gong, Thomas A Fox, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.
Blood|April 19, 2013
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLLAnna Vardi, Antonis Dagklis, Lydia Scarfò, et al.
Leukemia|March 21, 2025
Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in miceChiara Rompietti, Francesco Maria Adamo, Daniele Sorcini, et al.
Hemasphere|July 26, 2023
The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK InhibitorsMarta Sampietro, Valeria Cassina, Domenico Salerno, et al.
Haematologica|May 18, 2019
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemiaMichael Steurer, Marco Montillo, Lydia Scarfò, et al.
Blood|May 4, 2017
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosisFrancesca Gorini, Laura Azzimonti, Gloria Delfanti, et al.
Blood|January 31, 2016
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironmentRoberta Valsecchi, Nadia Coltella, Daniela Belloni, et al.
Blood|August 3, 2022
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLLLydia Scarfò, Silvia Heltai, Elisa Albi, et al.
Nature Communications|December 30, 2025
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1Paolo G Cocomazzi, Anastasia Iatrou, Claudia Minici, et al.
Blood|October 28, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Inna Y Gong, Thomas A Fox, et al.
Pageof 12